AHS Sponsorship

The generous support of our sponsors contributes to our mission of improving the lives of those impacted by migraine and other headache disorders by driving advancements in headache medicine and patient care.

Sponsorship Opportunities

AHS offers a range of sponsorship opportunities to support its mission of advancing headache medicine. Sponsors can engage with cutting-edge educational programming providing knowledge and practical skills to improve patient care, leadership development initiatives offering professionals a chance to refine their leadership capabilities, and early career training programs that aim to inspire a long-term interest in the field. Additionally, AHS facilitates groundbreaking research through funding opportunities, helping sponsors contribute to scientific advancements.

The Annual Scientific Meeting shares the latest advances in headache and migraine research, uniting care providers and researchers to improve lives and advance the AHS mission.

View the Prospectus

The Scottsdale Headache Symposium draws clinicians and health professionals who treat headache and pain, including neurologists, GPs, internists, pediatricians, NPs, PAs, and nurses.

Learn more about the Event

Bolstered by the Allergan neuroscience legacy, AbbVie is a committed leader in migraine with an almost 25-year history in migraine research. Our current migraine treatments demonstrate our dedication to addressing the unmet needs of migraine patients – and we continue to strive for science that makes a difference.

Contact Email: customerservice@abbvie.com

Visit Site

Lundbeck is a global biopharmaceutical company focusing exclusively on brain health. With more than 70 years of experience in neuroscience, we are committed to improving the lives of people with neurological and psychiatric diseases. Brain disorders affect a large part of the world’s population, and the effects are felt throughout society. With the rapidly improving understanding of the biology of the brain, we hold ourselves accountable for advancing brain health by curiously exploring new opportunities for treatment. To learn more, visit www.lundbeckus.com.

Contact Email: ESM@lundbeck.com

Visit Site

At Pfizer, we’re in relentless pursuit of breakthroughs that change patients’ lives. We’re committed to helping migraine patients around the world, and also to help further the conversation around migraine and its impact on people’s lives through the lens of those who live with Migraine. Using our global presence and scale, we’re able to make a difference in local communities and the world around us.

Contact Name: Brian Fitzpatrick

Contact Email: Brian.Fitzpatrick4@pfizer.com

Visit Site

Axsome is developing therapies for CNS conditions with limited treatment options. By creating treatments with novel mechanisms of action, we are transforming the approach to treating CNS conditions. At Axsome, we are committed to developing therapeutic approaches that meaningfully improve the lives of patients and provide additional options for physicians.

Visit Site

Ipsen is a global biopharmaceutical company focused on innovation and specialty care. At Ipsen, we work to provide hope for patients whose lives are challenged by difficult to treat diseases. The patients we serve live with rare and debilitating diseases, and we pride ourselves on putting these patients first. We are always ready to listen to and learn from patients. Every day, our more than 5,700 employees worldwide, including over 600 in North America, work diligently to improve the lives of patients around the world. For more information please visit www.ipsenus.com

Visit Site